Opportunity Information: Apply for PAR 15 332
Apply for PAR 15 332
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Early Stage Development of Informatics Technologies for Cancer Research and Management (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396 Cancer Biology Research.
- This funding opportunity was created on Aug 18, 2015 and posted on Aug 18, 2015.
- Applicants must submit their applications by Jun 14, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: Public housing authorities/Indian housing authorities Special district governments City or township governments Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Private institutions of higher education State governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Early Stage Development of Informatics Technologies for Cancer Research and Management (U01) funding opportunity (PAR-15-332) is a National Institutes of Health cooperative agreement announcement that supports the creation or major enhancement of informatics tools aimed at strengthening how cancer-related data and knowledge are collected, managed, analyzed, and shared. It sits within the National Cancer Institute (NCI) Informatics Technology for Cancer Research (ITCR) Program and is meant to move promising informatics ideas through early development work so they become more usable, more robust, and better suited to real research settings. The scope is broad across the cancer research continuum, including basic cancer biology, diagnosis and treatment, prevention, cancer control and epidemiology, and efforts tied to understanding and reducing cancer health disparities.
A central theme of this FOA is "early stage development," which it defines as either building a new tool from the ground up or making a significant modification to an existing tool so it can serve a new application or research need. The work is expected to cover activities such as prototyping, "hardening" (making software more stable, reliable, secure, and maintainable), and adaptation for new contexts. In other words, it is not just about publishing an algorithm or a proof of concept; the expectation is to develop enabling technology that can realistically be taken up by cancer researchers and integrated into workflows where it can have practical impact.
Because this is a U01 cooperative agreement, applicants should anticipate an active partnership model with NIH/NCI program staff rather than a fully hands-off grant structure. The emphasis is on research-driven informatics technology that addresses priority needs in cancer research, and applications are expected to explain clearly why the proposed technology is needed, what gap it fills, and how it will benefit the broader cancer research community. A strong application under this FOA would typically make a convincing case that the tool addresses a real bottleneck in handling cancer data or knowledge, and that the team has a credible plan to turn the concept into a functioning, usable, and maintainable product.
Another major requirement is user engagement throughout development. The FOA explicitly calls for mechanisms to solicit feedback from users and collaborators during the build process, signaling that iterative design and real-world testing are important. This can include plans for pilot users, advisory input from domain scientists, usability testing, documentation practices, and other structured approaches for incorporating user needs so the end result is not only technically sound but also practical and adoptable by the intended audience.
Administrative details included in the source information indicate the opportunity was posted August 18, 2015, with an original and current closing date of June 14, 2018, and an archive date of July 15, 2018. The listed award ceiling is $300,000, and there is no cost sharing or matching requirement. The funding activity category is listed under Education/Health, with CFDA number 93.396 (Cancer Biology Research). Eligibility is broad and includes many types of U.S. and non-U.S. organizations and government entities, such as public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), for-profit organizations (including small businesses), state, county, city/township, and special district governments, tribal governments and tribal organizations, U.S. territories and possessions, and foreign organizations. The eligibility notes also highlight inclusion of various designated institution types such as HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations, along with eligible federal agencies and regional organizations.
Overall, this FOA is designed to help teams build and substantially strengthen informatics technologies that can enable better cancer research and management by improving data and knowledge workflows across multiple domains. The most competitive projects under this opportunity are those that pair a well-justified, high-need informatics problem with a realistic early-stage development plan, measurable progress from prototype toward a dependable tool, and an intentional strategy for continuous input from the researchers and stakeholders who will ultimately use the technology.
FAQs: Early Stage Development of Informatics Technologies for Cancer Research and Management (U01) (PAR-15-332)
What is PAR-15-332?
PAR-15-332 is a National Institutes of Health (NIH) cooperative agreement funding opportunity (U01) focused on the early stage development of informatics technologies for cancer research and management.
What is the main purpose of this funding opportunity?
The opportunity supports the creation or major enhancement of informatics tools that strengthen how cancer-related data and knowledge are collected, managed, analyzed, and shared, with the goal of producing technology that can realistically be adopted in real research settings.
Which NIH institute/program is this associated with?
This opportunity sits within the National Cancer Institute (NCI) Informatics Technology for Cancer Research (ITCR) Program.
What does "early stage development" mean in this FOA?
"Early stage development" is defined as either (1) building a new informatics tool from the ground up, or (2) making a significant modification to an existing tool so it can serve a new application or research need. The expectation goes beyond a proof of concept and targets development toward a usable, robust tool.
What types of development activities does the FOA expect?
The FOA expects activities such as prototyping, "hardening" (improving stability, reliability, security, and maintainability), and adapting tools for new contexts so they fit real-world workflows and practical research needs.
Is this funding meant for algorithms or proofs of concept only?
No. The FOA emphasizes enabling technology development rather than just publishing an algorithm or demonstrating a limited proof of concept. Projects are expected to move a promising idea toward a functioning, usable, and maintainable tool that researchers can take up.
What areas of cancer research are within scope?
The scope is broad across the cancer research continuum, including basic cancer biology, diagnosis and treatment, prevention, cancer control and epidemiology, and efforts related to understanding and reducing cancer health disparities.
What kinds of problems or gaps should a proposed tool address?
Applications are expected to clearly explain why the proposed technology is needed, what gap it fills, and how it benefits the broader cancer research community. Strong projects typically address a real bottleneck in handling cancer data or knowledge.
What is the funding mechanism and what does it imply for the project relationship with NIH/NCI?
This is a U01 cooperative agreement, which implies an active partnership model with NIH/NCI program staff rather than a fully hands-off grant structure. Applicants should expect involvement consistent with a cooperative agreement model.
Is user engagement required during development?
Yes. The FOA explicitly calls for user engagement throughout development and expects mechanisms to solicit feedback from users and collaborators during the build process.
What are examples of acceptable user engagement mechanisms mentioned or implied by the FOA?
Examples include plans for pilot users, advisory input from domain scientists, usability testing, documentation practices, and other structured approaches for incorporating user needs so the end result is practical and adoptable.
What makes an application competitive under this FOA?
The most competitive projects typically pair (1) a well-justified, high-need informatics problem, (2) a realistic early-stage development plan with measurable progress from prototype toward a dependable tool, and (3) an intentional strategy for continuous input from the researchers and stakeholders who will use the technology.
What is the award ceiling listed for this opportunity?
The listed award ceiling is $300,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
When was this opportunity posted and when did it close?
It was posted on August 18, 2015. The original and current closing date listed is June 14, 2018, and the archive date is July 15, 2018.
What is the funding activity category and CFDA number provided?
The funding activity category is listed under Education/Health, and the CFDA number provided is 93.396 (Cancer Biology Research).
Who is eligible to apply?
Eligibility is broad and includes many types of U.S. and non-U.S. organizations and government entities. Examples listed include public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), for-profit organizations (including small businesses), and various government entities.
Are non-U.S. organizations eligible?
Yes. The eligibility information explicitly includes foreign organizations.
What types of government entities are included in the eligibility list?
The eligibility list includes state, county, city/township, and special district governments, tribal governments and tribal organizations, as well as U.S. territories and possessions. It also notes eligible federal agencies and regional organizations.
Are minority-serving institutions and community-based organizations included as eligible?
Yes. The eligibility notes highlight inclusion of designated institution types such as HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations.
What is the overall goal of the FOA for the cancer research community?
The overall goal is to enable better cancer research and management by building and substantially strengthening informatics technologies that improve cancer data and knowledge workflows across multiple domains.
Browse more opportunities from the same category: Education Health
Next opportunity: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
Previous opportunity: Building Capacity for 50th Anniversary
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 332
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 332) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24) Apply for PAR 15 331 Funding Number: PAR 15 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $600,000 |
| Sustained Support for Informatics Resources for Cancer Research and Management (U24) Apply for PAR 15 333 Funding Number: PAR 15 333 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) Apply for PAR 15 334 Funding Number: PAR 15 334 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory Multi site Palliative Care Research in Diverse Populations Utilizing the Palliative Care Research Cooperative (PCRC) Group (R21) Apply for PAR 15 337 Funding Number: PAR 15 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NIDA Translational Avant Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) Apply for RFA DA 16 008 Funding Number: RFA DA 16 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 15 340 Funding Number: PAR 15 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Centers for Cancer Systems Biology Consortium(U54) Apply for RFA CA 15 014 Funding Number: RFA CA 15 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,500,000 |
| Coordinating Center for Cancer Systems Biology Consortium (U24) Apply for RFA CA 15 015 Funding Number: RFA CA 15 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Behavioral Pharmacology and Genetics Translating and Targeting Individual Differences (R03) Apply for RFA DA 09 016 Funding Number: RFA DA 09 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biosignatures of Chronic Drug Exposure (R21) Apply for RFA DA 09 022 Funding Number: RFA DA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01) Apply for PAS 09 001 Funding Number: PAS 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants Program for Cancer Epidemiology (R03) Apply for PAR 08 237 Funding Number: PAR 08 237 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Unique Interactions Between Tobacco Use and HIV/AIDS (R01) Apply for PA 08 253 Funding Number: PA 08 253 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Unique Interactions Between Tobacco Use and HIV/AIDS (R03) Apply for PA 08 254 Funding Number: PA 08 254 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R01) Apply for PA 08 263 Funding Number: PA 08 263 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Small Grants for Behavioral Research in Cancer Control (R03) Apply for PAR 09 003 Funding Number: PAR 09 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery(R01) Apply for PA 09 004 Funding Number: PA 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies on Cancer Health Care Delivery (R21) Apply for PA 09 005 Funding Number: PA 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R21) Apply for PA 08 264 Funding Number: PA 08 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R03) Apply for PA 08 265 Funding Number: PA 08 265 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 332", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.